Hit enter after type your search item
Home / COVID-19 / Canada announces steps in treating and preventing COVID-19

Canada announces steps in treating and preventing COVID-19

/
img

Canada announces steps in treating and preventing COVID-19 as part of its aggressive pursuit in the purchase and development of COVID-19 vaccines, treatments and related supplies it has signed new deals with pharmaceutical firms Pfizer and Moderna to secure millions of doses of the vaccines they are developing.

“The contracts reflect the requirement for Health Canada approval, and in particular, once that has occurred, we are expecting deliveries, if all goes well, in 2021,” said Anita Anand, Minister of Public Services and Procurement on Wednesday. “Any vaccine would still need to be approved by Health Canada before being rolled out,” said Anand.

The government also plans to continue engaging with international and domestic scientists and with businesses and manufacturers that are stepping up to fight COVID-19.

The Government of Canada says it is investing in projects that will position Canada at the forefront of the global race to find a treatment and a vaccine for COVID-19, while building domestic capabilities to fight future pandemics.

The Honourable Navdeep Bains, Minister of Innovation, Science and Industry
The Honourable Navdeep Bains has been the Member of Parliament for Mississauga—Malton since 2015, and was previously the Member of Parliament for Mississauga—Brampton South from 2004 to 2011.

The Honourable Navdeep Bains, Minister of Innovation, Science and Industry (ISED), and the Honourable Anita Anand, Minister of Public Services and Procurement (PSPC), today announced several measures being taken by the Government of Canada to secure a future supply of COVID-19 vaccine and therapies.

“The Government is committed to protecting the health and safety of Canadians. That’s why we are working hard on all possible fronts to deliver safe and effective treatments and vaccines against COVID-19 for Canadians as fast as possible,” said Navdeep Bains, Minister of Innovation, Science and Industry..

“Guided by the expertise of these task forces, which has informed the VBI investment announced today, we are leaving no stone unturned in exploring every promising option to enhance our research and development capacity for long-term emergency preparedness,” said Bains.

Minister Bains unveiled the members of the COVID-19 Vaccine Task Force, who are advising the Government on how best to support vaccine research in Canada and help ensure Canadian leadership in vaccine development, related bio-manufacturing and international partnerships to secure access for Canadians to safe and effective products.

The Vaccine Task Force includes vaccine and immunology experts, as well as industry leaders with a proven ability in developing and commercializing vaccines

The Vaccine Task Force includes vaccine and immunology experts, as well as industry leaders with a proven ability in developing and commercializing vaccines. The co-chairs are Joanne Langley, Head of Infectious Diseases at the IWK Health Centre in Halifax and Professor in the Department of Community Health and Epidemiology at Dalhousie University, and J. Mark Lievonen, former President of Sanofi Pasteur Limited in Canada.

Task Force members have reviewed vaccine and bio-manufacturing applications from domestic candidates for which it has provided advice to the ministers of ISED and Health on the most promising options aimed at providing Canadians with safe, effective vaccines as soon as possible, as well as a robust manufacturing sector to increase secure access to vaccine production. The Task Force has also provided scientific and technical advice to the government on a portfolio of leading international vaccine candidates. 

Minister Anand announced that, following the careful review and recommendation of the COVID-19 Vaccine Task Force, the Government of Canada has entered into two agreements with Pfizer and Moderna to secure millions of doses of COVID-19 vaccine candidates. Pfizer will supply its BNT162 mRNA-based vaccine candidate, while Moderna will provide its mRNA-1273 vaccine candidate. All potential vaccines will require Health Canada regulatory approval prior to being used to vaccinate Canadians. Active negotiations with other potential vaccine suppliers are also under way.

The Honourable Anita Anand, Minister of Public Services and Procurement
he Honourable Anita Anand was first elected as the Member of Parliament for Oakville in 2019.

“Since the beginning of the pandemic, we have been working diligently to secure the necessary personal protective equipment and supplies needed to protect frontline healthcare workers and combat COVID-19,” said Anita Anand, Minister of Public Services and Procurement.

Government of Canada reaches agreement with Pfizer and Moderna

“While that work continues, we are now squarely focused on preparing Canada for an eventual vaccine. Given intense global competition, we are taking an aggressive approach to secure access to the most promising candidates so that we will be ready to vaccinate all Canadians as quickly as possible. We are extremely pleased to establish these agreements with Pfizer and Moderna. Canadians can rest assured that the Government will continue to do everything possible to keep them healthy and safe,” said Anand.

The Government is negotiating and signing agreements with a number of leading pharmaceutical companies to establish a guaranteed supply base of potential vaccine candidates.

PSPC is also procuring the equipment and supplies that will be needed to perform the final manufacturing and packaging stages of vaccine production in Canada, as well as the materials needed to support safe, efficient immunization such as syringes, needles, alcohol swabs and other supplies.

In addition, following the recommendation of the COVID-19 Vaccine Task Force, Minister Bains announced an investment of up to $56 million to support clinical trials for a COVID-related vaccine candidate from Variation Biotechnologies Inc. (VBI) through the Strategic Innovation Fund. VBI’s project is in direct response to the global fight against COVID-19 and contributes to Canada’s ability to secure an effective vaccine. This investment is funded from the Government’s $600 million to support COVID-19–related vaccine and therapy clinical trials led by the private sector and to support Canadian bio-manufacturing opportunities. Other projects are still under consideration.

Minister Bains also announced the members of the COVID-19 Therapeutics Task Force. The Therapeutics Task Force is providing expert advice to the Government on the development of COVID-19 treatments, including how best to prioritize financial support for promising COVID-19 treatment projects. The Task Force includes experts drawn from research and industry who have a proven ability to develop and bring new therapies to market in Canada. The Therapeutics Task Force is co-chaired by Nancy Harrison, Director and Past Chair of LifeSciences BC, and Cédric Bisson, Partner at Teralys Capital.

From the beginning, the Government has worked across all departments and agencies to meet the challenges posed by COVID-19 with the goal of protecting the health of all Canadians. Today, the Government also announced investments that will help support the development of and access to treatments for COVID-19, including:

Other articles from mtltimes.ca and totimes.ca

Rising Montreal homeless

Rising Montreal homeless setting up camps in public areas

Covid-19 outbreak on one of the first cruise ships

Covid-19 outbreak on one of the first cruise ships to resume operations

  • Facebook
  • Twitter
  • Linkedin
  • Pinterest

Leave a Comment

This div height required for enabling the sticky sidebar
Ad Clicks :Ad Views : Ad Clicks :Ad Views :
%d bloggers like this: